Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 29, 2015 - Issue 10
509
Views
31
CrossRef citations to date
0
Altmetric
Short Communication

Studies on α-glucosidase, aldose reductase and glycation inhibitory properties of sesquiterpenes and flavonoids of Zingiber zerumbet Smith

, , , , , & show all
Pages 947-952 | Received 30 May 2014, Accepted 18 Aug 2014, Published online: 09 Sep 2014

References

  • AbdelwahabSI, AbdulAB, MohanS, TahaMM, SyamS, IbrahimMY, MariodAA. 2011. Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells. Leuk Res. 35:268–271.
  • AbdelwahabSI, AbdulAB, ZainZN, HadiAH. 2012. Zerumbone inhibits interleukin-6 and induces apoptosis and cell cycle arrest in ovarian and cervical cancer cells. Int Immunopharmacol. 12:594–602.
  • AggarwalBB, AjaikumarBK, HarikumarKB, SheejaTT, SungB, AnandP. 2008. Potential of spice-derived phytochemicals for cancer prevention. Planta Med. 74:1560–1569 and references therein.
  • AhmedN. 2005. Advanced glycation end products: role in pathology of diabetic complications. Diabetes Res Clin Pract. 67:3–21.
  • ApostolidisE, KwonYI, ShettyK. 2007. Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innov Food Sci Emerg Technol. 8:46–54.
  • BabyS, DanM, ThahaARM, JohnsonAJ, KurupR, BalakrishnapillaiP, LimCK. 2009. High content of zerumbone in volatile oils of Zingiber zerumbet from southern India and Malaysia. Flavour Fragr J. 24:301–308.
  • ChungSS, HoEC, LamKS, ChungSK. 2003. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol. 14:S233–S236.
  • ChungSSM, ChungSK. 2005. Aldose reductase in diabetic microvascular complications. Curr Drug Targets. 6:475–486.
  • ChungSY, JangDS, HanA-R, JangJO, KwonY, SeoE-K, LeeHJ. 2007. Modulation of P-glycoprotein-mediated resistance by kaempferol derivatives isolated from Zingiber zerumbet. Phytother Res. 21:565–569.
  • DaiJR, CardellinaJH, McMahonJB, BoydMR. 1997. Zerumbone, an HIV-inhibitory and cytotoxic sesquiterpene of Zingiber aromaticum and Z. zerumbet. Nat Prod Lett. 10:115–118.
  • DamodaranNP, DevS. 1965. Stereochemistry of zerumbone. Tetrahedron Lett. 24:1977–1981.
  • DanaeiG, FinucaneMM, LuY, SinghGM, CowanMJ, PaciorekCJ, LinJK, FarzadfarF, KhangYH, StevensGA, et al. 2011. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 378:31–40.
  • DevS. 1960. Studies in sesquiterpenes-xvi zerumbone, a monocyclic sesquiterpene ketone. Tetrahedron. 8:171–180.
  • GabbayKH. 1973. The sorbitol pathway and the complications of diabetes. N Engl J Med. 288:831–836.
  • GoldinA, BeckmanJA, SchmidtAM, CreagerMA. 2006. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 114:597–605.
  • HuangGC, ChienTY, ChenLG, WangCC. 2005. Antitumor effects of zerumbone from Zingiber zerumbet in P-388D 1 cells in vitro and in vivo. Plant Med. 71:219–224.
  • JangDS, HanA-R, ParkG, JhonG-J, SeoE-K. 2004. Flavonoids and aromatic compounds from the rhizomes of Zingiber zerumbet. Arch Pharm Res.27:386–389.
  • JianboX, GuoyinK, KoichiroY, XiaoqingC. 2013. Advance in dietary polyphenols as α-glucosidases inhibitors: a review on structure–activity relationship aspect. Crit Rev Food Sci Nutr. 53:818–836.
  • KaderMG, HabibMR, NikkonF, YeasminT, RashidMA, RahmanMM, GibbonsS. 2009. Zederone from the rhizomes of Zingiber zerumbet and its antistaphylococcal Activity. Bol Latinoam Caribe Plant Med Aromat. 9:63–68.
  • KashyapSR, DefronzoRA. 2007. The Insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res. 4:13–19.
  • KiranaC, McIntoshGH, RecordIR, JonesGP. 2003. Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone. Nutr Cancer. 45:218–225.
  • KitayamaT, OkamotoT, HillRK, KawaiY, TakahashiS, YonemoriS, YamamotoY, OheK, UemuraS, SawadaS. 1999. Chemistry of zerumbone. 1. Simplified isolation, conjugate addition reactions, and a unique ring contracting transannular reaction of its dibromide. J Org Chem. 64:2667–2672.
  • MasudaT, JitoeA, KatoS, NakataniN. 1991. Acetylated flavonoid glycosides from Zingiber zerumbet. Phytochemistry. 30:2391–2392.
  • MurakamiA, MiyamotoM, OhigashiH. 2004. Zerumbone, an anti-inflammatory phytochemical, induces expression of proinflammatory cytokine genes in human colon adenocarcinoma cell lines. Biofactor. 21:95–101.
  • MurakamiA, OhigashiH. 2007. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer. 121:2357–2363.
  • MurakamiA, TanakaT, LeeJY, SurhYJ, KimHW, KawabataK, NakamuraY, JiwajindaS, OhigashiH. 2004. Zerumbone, a sesquiterpene in subtropical ginger, suppresses skin tumor initiation and promotion stages in ICR mice. Int J Cancer. 110:481–490.
  • NakataniN, JitoeA, MasudaT, YonemoriS. 1991. Flavonoid constituents of Zingiber zerumbet Smith. Agric Biol Chem. 55:455–460.
  • NeuenschwanderU, CzarnieckiB, HermansI. 2012. Origin of regioselectivity in α-humulene functionalization. J Org Chem. 77:2865–2869.
  • OsonoiT, SaitoM, MochizukiK, FukayaN, MuramatsuT, InoueS, FuchigamiM, GodaT. 2010. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus. Metabolism. 59:1816–1822.
  • OzakiY, KawaharaN, HaradaM. 1991. Anti-inflammatory effect of Zingiber cassumunar Roxb and its active principles. Chem Pharm Bull. 39:2353–2356.
  • PrakashRO, RabinarayanA, KumarMS. 2011. Zingiber zerumbet (L.) Sm., a reservoir plant for therapeutic uses: a review. Int J Pharma World Res. 2:1–23.
  • PriyaRM, PadmakumariKP, SankarikuttyB, LijocheriyanO, NishaVM, RaghuKG. 2011. Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. Int J Food Sci Nutr. 62:106–110.
  • RiyaMP, AntuKA, VinuT, ChandrakanthKC, AnilkumarKS, RaghuKG. 2013. doi:10.1002/jsfa.6340An in vitro study reveals nutraceutical properties of Ananas comosus (L.) Merr. var. Mauritius residue beneficial to diabetes. J Sci Food Agric.
  • SinghCB, NongalleimaKh, BrojendrosinghS, NingombamS, LokendrajitN, SinghLW. 2012. Biological and chemical properties of Zingiber zerumbet Smith: a review. Phytochem Rev. 11:113–125.
  • SulaimanMR, PerimalEK, AkhtarMN, MohamadAS, KhalidMH, TasripNA, MokhtarF, ZakariaZA, LajisNH, IsrafDA. 2010. Anti-inflammatory effect of zerumbone on acute and chronic inflammation models in mice. Fitoterapia. 81:855–858.
  • SungB, PrasadS, YadavVR, AggarwalBB. 2012. Cancer cell signaling pathways targeted by spice-derived nutraceuticals. Nutr Cancer. 64:173–197.
  • SzabolcsA, TiszlaviczL, KaszakiJ, PósaA, BerkóA, VargaIS, BorosI, SzütsV, LonovicsJ, TakácsT. 2007. Zerumbone exerts a beneficial effect on inflammatory parameters of cholecystokinin octapeptide-induced experimental pancreatitis but fails to improve histology. Pancreas. 35:249–255.
  • TahaMM, AbdulAB, AbdullahR, IbrahimTA, AbdelwahabSI, MohanS. 2010. Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet). Chem Biol Interact. 186:295–305.
  • TzengTF, LiouSS, ChangCJ, LiuIM. 2013a. The ethanol extract of Zingiber zerumbet attenuates streptozotocin-induced diabetic nephropathy in rats. Evid Based Complement Alternat Med. 2013:340645.
  • TzengTF, LiouSS, ChangCJ, LiuIM. 2013b. Zerumbone, a tropical ginger sesquiterpene, ameliorates streptozotocin induced diabetic nephropathy in rats by reducing the hyperglycemia induced inflammatory response. Nutr Metab (Lond). 10:64/1–64/12.
  • VasanS, FoilesPG, FoundsHW. 2001. Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links. Exp Opin Invest Drugs. 10:1977–1987.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.